Immage Biotherapeutics (IMMG) Price & Analysis

0 Followers

IMMG Stock Chart & Stats

$0.01

$0.00(0.00%)

At close: Feb 12 4:00 PM EST

$0.01

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.01 - $0.01

Previous CloseN/A

Volume500.00

Average Volume (3M)0.00

Market Cap

$152.00

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.00

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding151,744,570

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

IMMG FAQ

What was Immage Biotherapeutics Corp.’s price range in the past 12 months?

Immage Biotherapeutics Corp. lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.

What is Immage Biotherapeutics Corp.’s market cap?

Immage Biotherapeutics Corp.’s market cap is $152.00.

When is Immage Biotherapeutics Corp.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Immage Biotherapeutics Corp.’s earnings last quarter?

Currently, no data Available

Is Immage Biotherapeutics Corp. overvalued?

According to Wall Street analysts Immage Biotherapeutics Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Immage Biotherapeutics Corp. pay dividends?

Immage Biotherapeutics Corp. does not currently pay dividends.

What is Immage Biotherapeutics Corp.’s EPS estimate?

Immage Biotherapeutics Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Immage Biotherapeutics Corp. have?

Immage Biotherapeutics Corp. has 151,744,570 shares outstanding.

What happened to Immage Biotherapeutics Corp.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Immage Biotherapeutics Corp.?

Currently, no hedge funds are holding shares in IMMG

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Immage Biotherapeutics Corp.

Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States. Established in 2012, the entity was initially known as Epicure Charcoal, Inc., rebranding to Immage Biotherapeutics Corp. in June 2015. Its corporate headquarters are situated in Bethesda, Maryland, and it operates as a subsidiary of Coventry International Limited.